A Review on Recent Technologies for the Manufacture of Pulmonary Drugs

References

• Traini D Young PM . Delivery of antibiotics to the respiratory tract: an update. Exp. Opin. Drug Deliv.6 (9), 897–905 (2009).
   PubMed Web of Science ®Google Scholar
• Labiris NR Dolovich MB . Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications. Br. J. Clin. Pharmacol.56 (6), 588–599 (2003).
   PubMed Web of Science ®Google Scholar
• Smola M Vandamme T Sokolowski A . Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases. Int. J. Nanomed.3 (1), 1–19 (2008).
   PubMed Web of Science ®Google Scholar
• Siekmeier R Scheuch G . Treatment of systemic diseases by inhalation of biomolecule aerosols. J. Physiol. Pharmacol.60 (Suppl. 5), 15–26 (2009).
   PubMedGoogle Scholar
• Traini D Young PM . Formulation of inhalation medicines. In : Inhalation Drug Delivery: Techniques and Products. ColomboPTrainiDButtiniF ( Eds). John Wiley & Sons, Ltd, Chichester, UK, 31–45 (2013).
   Google Scholar
• Zhou QT Leung SSY Tang P Parumasivam T Loh ZH Chan HK . Inhaled formulations and pulmonary drug delivery systems for respiratory infections. Adv. Drug Deliv. Rev.85, 83–99 (2015).
   PubMed Web of Science ®Google Scholar
• Ibrahim M Verma R Garcia-Contreras L . Inhalation drug delivery devices: technology update. Med. Devices (Auckl).8, 131–139 (2015).
   PubMedGoogle Scholar
• Dal Negro RW . Dry powder inhalers and the right things to remember: a concept review. Multidisciplinary Resp. Med.10 (1), 13 (2015).
   PubMedGoogle Scholar
• Copley M . Regulatory challenges of inhaler testing. Pharmaceutical Technology Europe. Advanstar Publishers. November 1st21 (11), 24–27 (2009).
   Google Scholar
• Groneberg DA Witt C Wagner U Chung KF Fischer A . Fundamentals of pulmonary drug delivery. Resp. Med.97 (4), 382–387 (2003).
   PubMed Web of Science ®Google Scholar
• Carvalho TC Peters JI Williams RO . Influence of particle size on regional lung deposition–what evidence is there?Int. J. Pharm.406 (1), 1–10 (2011).
   PubMedGoogle Scholar
• Swarbrick J Boylan JC . Encyclopedia of Pharmaceutical Technology: Volume 20 (Supplement 3). CRC Press, Boca Raton, Florida (2000).
   Google Scholar
• Zhang J Ebbens S Chen X et al. Determination of the surface free energy of crystalline and amorphous lactose by atomic force microscopy adhesion measurement. Pharm. Res.23 (2), 401–407 (2006).
   PubMed Web of Science ®Google Scholar
• Mortensen NP Durham P Hickey AJ . The role of particle physico-chemical properties in pulmonary drug delivery for tuberculosis therapy. J. Microencapsulation31 (8), 785–795 (2014).
   PubMed Web of Science ®Google Scholar
• Traini D . Inhalation drug delivery. In : Inhalation Drug Delivery: Techniques and Products. ColomboPTrainiDButtiniF ( Eds). John Wiley & Sons, Ltd, Chichester, UK, 1–14 (2013).
   Google Scholar
• Ziffels S Bemelmans NL Durham PG Hickey AJ . In vitro dry powder inhaler formulation performance considerations. J. Control. Rel.199 (Suppl. C), 45–52 (2015).
   PubMedGoogle Scholar
• Lee SL Adams WP Li BV Conner DP Chowdhury BA Lawrence XY . In vitro considerations to support bioequivalence of locally acting drugs in dry powder inhalers for lung diseases. AAPS J.11 (3), 414–423 (2009).
   PubMed Web of Science ®Google Scholar
• Chow AHL Tong HHY Chattopadhyay P Shekunov BY . Particle engineering for pulmonary drug delivery. Pharm. Res.24 (3), 411–437 (2007).
   PubMed Web of Science ®Google Scholar
• Crowder TM Rosati JA Schroeter JD Hickey AJ Martonen TB . Fundamental effects of particle morphology on lung delivery: predictions of Stokes’ law and the particular relevance to dry powder inhaler formulation and development. Pharm. Res.19 (3), 239–245 (2002).
   PubMed Web of Science ®Google Scholar
• Shekunov BY Chattopadhyay P Tong HH Chow AH . Particle size analysis in pharmaceutics: principles, methods and applications. Pharm. Res.24 (2), 203–227 (2007).
   PubMed Web of Science ®Google Scholar
• Tang P Chan HK Raper JA . Prediction of aerodynamic diameter of particles with rough surfaces. Powder Technol.147 (1), 64–78 (2004).
   Web of Science ®Google Scholar
• Kaialy W Ticehurst M Nokhodchi A . Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate. Int. J. Pharm.423 (2), 184–194 (2012).
   PubMedGoogle Scholar
• Kaialy W Martin GP Larhrib H Ticehurst MD Kolosionek E Nokhodchi A . The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers. Colloids and Surfaces B: Biointerfaces89, 29–39 (2012).
   PubMed Web of Science ®Google Scholar
• Burnett DJ Heng JYY Thielmann F Garcia AR Naderi M Acharya M . Measuring surface roughness of pharmaceutical powders using vapor sorption methods. AAPS PharmSciTech.12 (1), 56–61 (2011).
   PubMed Web of Science ®Google Scholar
• Tang P Chew NYK Chan HK Raper JA . Limitation of determination of surface fractal dimension using N2 adsorption isotherms and modified Frenkel-Halsey-Hill theory. Langmuir19 (7), 2632–2638 (2003).
   Web of Science ®Google Scholar
• Peng T Lin S Niu B et al. Influence of physical properties of carrier on the performance of dry powder inhalers. Acta Pharmaceutica Sinica B6 (4), 308–318 (2016).
   PubMed Web of Science ®Google Scholar
• Parsian AR Vatanara A Rahmati MR Gilani K Khosravi KM Najafabadi AR . Inhalable budesonide porous microparticles tailored by spray freeze drying technique. Powder Technol.260, 36–41 (2014).
   Web of Science ®Google Scholar
• Hassan MS Lau RWM . Effect of particle shape on dry particle inhalation: study of flowability, aerosolization, and deposition properties. AAPS PharmSciTech.10 (4), 1252–1262 (2009).
   PubMed Web of Science ®Google Scholar
• Kho K Hadinoto K . Dry powder inhaler delivery of amorphous drug nanoparticles: effects of the lactose carrier particle shape and size. Powder Technol.233, 303–311 (2013).
   Web of Science ®Google Scholar
• Chan LW Tan LH Heng PWS . Process analytical technology: application to particle sizing in spray drying. AAPS PharmSciTech.9 (1), 259–266 (2008).
   PubMed Web of Science ®Google Scholar
• Medendorp J Bric J Connelly G Tolton K Warman M . Development and beyond: strategy for long-term maintenance of an online laser diffraction particle size method in a spray drying manufacturing process. J. Pharm. Biomed. Anal.112, 79–84 (2015).
   PubMed Web of Science ®Google Scholar
• Schorsch S Ochsenbein DR Vetter T Morari M Mazzotti M . High accuracy online measurement of multidimensional particle size distributions during crystallization. Chem. Eng. Sci.105, 155–168 (2014).
   Web of Science ®Google Scholar
• Corn M . The adhesion of solid particles to solid surfaces, I. A review. J. Air Pollut. Control Assoc.11 (11), 523–528 (1961).
   PubMedGoogle Scholar
• Murnane D Martin GP Marriott C . Dry powder formulations for inhalation of fluticasone propionate and salmeterol xinafoate microcrystals. J. Pharm. Sci.98 (2), 503–515 (2009).
   PubMed Web of Science ®Google Scholar
• Royall PG Woodhead B Tang SJ Martin GP Stockton BM Murnane D . Formation and measurement of process induced disorder during the manufacture of inhalation medicines. J. Drug Deliv. Sci. Technol.21 (4), 311–318 (2011).
   Web of Science ®Google Scholar
• Le V Thi TH Robins E Flament M . Dry powder inhalers: study of the parameters influencing adhesion and dispersion of fluticasone propionate. AAPS PharmSciTech.13 (2), 477–484 (2012).
   PubMed Web of Science ®Google Scholar
• Kaialy W Larhrib H Nokhodchi A . The effect of carrier particle size on adhesion, content uniformity and inhalation performance of budesonide using dry powder inhalers. In : Particulate Materials: Synthesis, Characterisation, Processing and Modelling. WuC-YGeW ( Eds). The Royal Society of Chemistry, United Kingdom, 113–119 (2012).
   Google Scholar
• Schoenherr C Haefele T Paulus K Francese G . Confocal Raman microscopy to probe content uniformity of a lipid based powder for inhalation: a quality by design approach. Eur. J. Pharm. Sci.38 (1), 47–54 (2009).
   PubMed Web of Science ®Google Scholar
• Gupta A Peck GE Miller RW Morris KR . Real-time near-infrared monitoring of content uniformity, moisture content, compact density, tensile strength, and Young's modulus of roller compacted powder blends. J. Pharm. Sci.94 (7), 1589–1597 (2005).
   PubMed Web of Science ®Google Scholar
• Lai CK Holt D Leung JC Cooney CL Raju GK Hansen P . Real time and noninvasive monitoring of dry powder blend homogeneity. AlChE J.47 (11), 2618–2622 (2001).
   Web of Science ®Google Scholar
• Seville PC Learoyd TP Li HY Williamson IJ Birchall JC . Amino acid-modified spray-dried powders with enhanced aerosolisation properties for pulmonary drug delivery. Powder Technol.178 (1), 40–50 (2007).
   Web of Science ®Google Scholar
• Zhao M You Y Ren Y Zhang Y Tang X . Formulation, characteristics and aerosolization performance of azithromycin DPI prepared by spray-drying. Powder Technol.187 (3), 214–221 (2008).
   Web of Science ®Google Scholar
• Simon A Amaro MI Cabral LM Healy AM De Sousa VP . Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate. Int. J. Pharm.501 (1), 124–138 (2016).
   PubMedGoogle Scholar
• Sou T Kaminskas LM Nguyen TH Carlberg R Mcintosh MP Morton DaV . The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules. Eur. J. Pharmaceut. Biopharmaceut.83 (2), 234–243 (2013).
   PubMed Web of Science ®Google Scholar
• Malamatari M Somavarapu S Kachrimanis K Buckton G Taylor KMG . Preparation of respirable nanoparticle agglomerates of the low melting and ductile drug ibuprofen: impact of formulation parameters. Powder Technol.308, 123–134 (2017).
   Web of Science ®Google Scholar
• Pilcer G Amighi K . Formulation strategy and use of excipients in pulmonary drug delivery. Int. J. Pharm.392 (1), 1–19 (2010).
   PubMedGoogle Scholar
• Hamishehkar H Rahimpour Y Javadzadeh Y . The role of carrier in dry powder inhaler. In : Recent Advances in Novel Drug Carrier Systems. SezerAD ( Ed.). InTech, United Kingdom (2012).
   Google Scholar
• Pilcer G Vanderbist F Amighi K . Spray-dried carrier-free dry powder tobramycin formulations with improved dispersion properties. J. Pharm. Sci.98 (4), 1463–1475 (2009).
   PubMed Web of Science ®Google Scholar
• Xu L-M Hu T-T Pu Y Le Y Chen J-F Wang J-X . Preparation of high-performance ultrafine budesonide particles for pulmonary drug delivery. Chem. Eng. J.252, 281–287 (2014).
   Web of Science ®Google Scholar
• Aoki Y Kojo Y Yamada S Onoue S . Respirable dry powder formulation of bleomycin for developing a pulmonary fibrosis animal model. J. Pharm. Sci.101 (6), 2074–2081 (2012).
   PubMed Web of Science ®Google Scholar
• Chiou H Li L Hu T Chan HK Chen JF Yun J . Production of salbutamol sulfate for inhalation by high-gravity controlled antisolvent precipitation. Int. J. Pharm.331 (1), 93–98 (2007).
   PubMedGoogle Scholar
• Chiou H Chan HK Heng D Prud'homme RK Raper JA . A novel production method for inhalable cyclosporine A powders by confined liquid impinging jet precipitation. J. Aerosol Sci39 (6), 500–509 (2008).
   Web of Science ®Google Scholar
• Dimer FA Ortiz M Pohlmann AR Guterres SS . Inhalable resveratrol microparticles produced by vibrational atomization spray drying for treating pulmonary arterial hypertension. J. Drug Deliv. Sci. Technol.29, 152–158 (2015).
   Web of Science ®Google Scholar
• Zhang H-X Wang J-X Zhang Z-B Le Y Shen Z-G Chen J-F . Micronization of atorvastatin calcium by antisolvent precipitation process. Int. J. Pharm.374 (1), 106–113 (2009).
   PubMedGoogle Scholar
• Shariare MH De Matas M York P . Effect of crystallisation conditions and feedstock morphology on the aerosolization performance of micronised salbutamol sulphate. Int. J. Pharm.415 (1–2), 62–72 (2011).
   PubMedGoogle Scholar
• Li Y Zhao X Zu Y et al. Preparation and characterization of micronized ellagic acid using antisolvent precipitation for oral delivery. Int. J. Pharm.486 (1), 207–216 (2015).
   PubMedGoogle Scholar
• Tierney TB Guo Y Beloshapkin S Rasmuson ÅC Hudson SP . Investigation of the particle growth of fenofibrate following antisolvent precipitation and freeze-drying. Crystal Growth & Design15 (11), 5213–5222 (2015).
   Web of Science ®Google Scholar
• Zu Y Sun W Zhao X et al. Preparation and characterization of amorphous amphotericin B nanoparticles for oral administration through liquid antisolvent precipitation. Eur. J. Pharm. Sci.53, 109–117 (2014).
   PubMed Web of Science ®Google Scholar
• Xu L-M Zhang Q-X Zhou Y Zhao H Wang J-X Chen J-F . Engineering drug ultrafine particles of beclomethasone dipropionate for dry powder inhalation. Int. J. Pharm.436 (1), 1–9 (2012).
   PubMedGoogle Scholar
• Son Y-J Mcconville JT . A new respirable form of rifampicin. Eur. J. Pharm. Biopharm.78 (3), 366–376 (2011).
   PubMed Web of Science ®Google Scholar
• Hu T Chiou H Chan HK Chen JF Yun J . Preparation of inhalable salbutamol sulphate using reactive high gravity controlled precipitation. J. Pharm. Sci.97 (2), 944–949 (2008).
   PubMed Web of Science ®Google Scholar
• Yang ZY Le Y Hu TT Shen Z Chen JF Yun J . Production of ultrafine sumatriptan succinate particles for pulmonary delivery. Pharm. Res.25 (9), 2012–2018 (2008).
   PubMed Web of Science ®Google Scholar
• Zhao H Le Y Liu H et al. Preparation of microsized spherical aggregates of ultrafine ciprofloxacin particles for dry powder inhalation (DPI). Powder Technol.194 (1), 81–86 (2009).
   Web of Science ®Google Scholar
• Schoubben A Blasi P Giovagnoli S Rossi C Ricci M . Development of a scalable procedure for fine calcium alginate particle preparation. Chem. Eng. J.160 (1), 363–369 (2010).
   Web of Science ®Google Scholar
• Cai X Yang Y Xie X et al. Preparation, characterization and pulmonary pharmacokinetics of a new inhalable zanamivir dry powder. Drug Delivery23 (6), 1962–1971 (2016).
   PubMed Web of Science ®Google Scholar
• Nolan LM Li J Tajber L Corrigan OI Healy AM . Particle engineering of materials for oral inhalation by dry powder inhalers. II–sodium cromoglicate. Int. J. Pharm.405 (1), 36–46 (2011).
   PubMedGoogle Scholar
• Nolan LM Tajber L Mcdonald BF Barham AS Corrigan OI Healy AM . Excipient-free nanoporous microparticles of budesonide for pulmonary delivery. Eur. J. Pharm. Sci.37 (5), 593–602 (2009).
   PubMed Web of Science ®Google Scholar
• Parikh R Dalwadi S . Preparation and characterization of controlled release poly-ε-caprolactone microparticles of isoniazid for drug delivery through pulmonary route. Powder Technol.264, 158–165 (2014).
   Web of Science ®Google Scholar
• Yang X-F Xu Y Qu D-S Zhu J Li H-Y . Excipient-free, spray-dried powders for pulmonary aztreonam delivery. J. Drug Deliv. Sci. Technol.28, 7–10 (2015).
   Web of Science ®Google Scholar
• Kim YH Shing KS . Supercritical fluid-micronized ipratropium bromide for pulmonary drug delivery. Powder Technol.182 (1), 25–32 (2008).
   Web of Science ®Google Scholar
• Adami R Reverchon E Järvenpää E Huopalahti R . Supercritical AntiSolvent micronization of nalmefene HCl on laboratory and pilot scale. Powder Technol.182 (1), 105–112 (2008).
   Web of Science ®Google Scholar
• Tavares Cardoso MA Geraldes V Cabral JMS Palavra AMF . Characterization of minocycline powder micronized by a supercritical antisolvent (SAS) process. J. Supercrit. Fluids46 (1), 71–76 (2008).
   Web of Science ®Google Scholar
• Li Z Jiang J Liu X Zhao S Xia Y Tang H . Preparation of erythromycin microparticles by supercritical fluid expansion depressurization. J. Supercritical Fluids41 (2), 285–292 (2007).
   Web of Science ®Google Scholar
• Zhiyi L Jingzhi J Xuewu L Yuanjing X Shunxuan Z Jian W . Preparation of tetracycline microparticles suitable for inhalation administration by supercritical fluid expansion depressurization. Chemical Engineering and Processing: Process Intensification47 (8), 1311–1316 (2008).
   Web of Science ®Google Scholar
• Zhiyi L Jingzhi J Xuewu L Huihua T Wei W . Experimental investigation on the micronization of aqueous cefadroxil by supercritical fluid technology. J. Supercrit. Fluids48 (3), 247–252 (2009).
   Web of Science ®Google Scholar
• Su CS Lo WS Lien LH . Micronization of fluticasone propionate using supercritical antisolvent (SAS) process. Chem. Eng. Technol.34 (4), 535–541 (2011).
   Web of Science ®Google Scholar
• Dhumal RS Biradar SV Paradkar AR York P . Particle engineering using sonocrystallization: salbutamol sulphate for pulmonary delivery. Int. J. Pharm.368 (1–2), 129–137 (2009).
   PubMedGoogle Scholar
• Muhammad SaFS Oubani H Abbas A Chan HK Kwok PCL Dehghani F . The production of dry powder by the sonocrystallisation for inhalation drug delivery. Powder Technol.246, 337–344 (2013).
   Web of Science ®Google Scholar
• El-Gendy N Huang S Selvam P Soni P Berkland C . Development of budesonide nanocluster dry powder aerosols: formulation and stability. J. Pharm. Sci.101 (9), 3445–3455 (2012).
   PubMed Web of Science ®Google Scholar
• Adi H Young PM Chan HK Agus H Traini D . Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease. Eur. J. Pharm. Sci.40 (3), 239–247 (2010).
   PubMed Web of Science ®Google Scholar
• Wu X Hayes D Jr Zwischenberger JB Kuhn RJ Mansour HM . Design and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalation. Drug Des. Devel. Ther.7, 59–72 (2013).
   PubMed Web of Science ®Google Scholar
• Khandouzi F Daman Z Gilani K . Optimized particle engineering of fluticasone propionate and salmeterol xinafoate by spray drying technique for dry powder inhalation. Adv. Powder Technol.28 (2), 534–542 (2017).
   Web of Science ®Google Scholar
• Li X Vogt FG Hayes D Jr Mansour HM . Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers. J. Pharm. Sci.103 (9), 2937–2949 (2014).
   PubMed Web of Science ®Google Scholar
• Xu EY Guo J Xu Y Li HY Seville PC . Influence of excipients on spray-dried powders for inhalation. Powder Technol.256, 217–223 (2014).
   Web of Science ®Google Scholar
• Kadota K Nishimura T Hotta D Tozuka Y . Preparation of composite particles of hydrophilic or hydrophobic drugs with highly branched cyclic dextrin via spray drying for dry powder inhalers. Powder Technol.283, 16–23 (2015).
   Web of Science ®Google Scholar
• Ober CA Kalombo L Swai H Gupta RB . Preparation of rifampicin/lactose microparticle composites by a supercritical antisolvent-drug excipient mixing technique for inhalation delivery. Powder Technol.236, 132–138 (2013).
   Web of Science ®Google Scholar
• Kim YH Sioutas C Fine P Shing KS . Effect of albumin on physical characteristics of drug particles produced by supercritical fluid technology. Powder Technol.182 (3), 354–363 (2008).
   Web of Science ®Google Scholar
• Yamasaki K Kwok PCL Fukushige K Prud'homme RK Chan HK . Enhanced dissolution of inhalable cyclosporine nano-matrix particles with mannitol as matrix former. Int. J. Pharm.420 (1), 34–42 (2011).
   PubMedGoogle Scholar
• Tajber L Corrigan DO Corrigan OI Healy AM . Spray drying of budesonide, formoterol fumarate and their composites-I. Physicochemical characterisation. Int. J. Pharm.367 (1–2), 79–85 (2009).
   PubMed Web of Science ®Google Scholar
• Ni R Zhao J Liu Q Liang Z Muenster U Mao S . Nanocrystals embedded in chitosan-based respirable swellable microparticles as dry powder for sustained pulmonary drug delivery. Eur. J. Pharm. Sci.99, 137–146 (2017).
   PubMed Web of Science ®Google Scholar
• Schoubben A Blasi P Giovagnoli S Ricci M Rossi C . Simple and scalable method for peptide inhalable powder production. Eur. J. Pharm. Sci.39 (1), 53–58 (2010).
   PubMed Web of Science ®Google Scholar
• Ni R Muenster U Zhao J et al. Exploring polyvinylpyrrolidone in the engineering of large porous PLGA microparticles via single emulsion method with tunable sustained release in the lung: in vitro and in vivo characterization. J. Control. Rel.249, 11–22 (2017).
   PubMed Web of Science ®Google Scholar
• Yang Y Bajaj N Xu P Ohn K Tsifansky MD Yeo Y . Development of highly porous large PLGA microparticles for pulmonary drug delivery. Biomaterials30 (10), 1947–1953 (2009).
   PubMed Web of Science ®Google Scholar
• Panchal R Patel H Patel V Joshi P Parikh A . Formulation and evalution of montelukast sodium-chitosan based spray dried microspheres for pulmonary drug delivery. J. Pharmacy Bioallied. Sci.4 (Suppl. 1), S110 (2012).
   PubMedGoogle Scholar
• Ceschan NE Bucalá V Ramírez-Rigo MV . Polymeric microparticles containing indomethacin for inhalatory administration. Powder Technol.285, 51–61 (2015).
   Web of Science ®Google Scholar
• Noraizaan AN Wong TW . Physicochemical effects of lactose microcarrier on inhalation performance of rifampicin in polymeric nanoparticles. Powder Technol.310, 272–281 (2017).
   Web of Science ®Google Scholar
• Fontana MC Durli TL Pohlmann AR Guterres SS Beck RCR . Polymeric controlled release inhalable powder produced by vibrational spray-drying: one-step preparation and in vitro lung deposition. Powder Technol.258, 49–59 (2014).
   Web of Science ®Google Scholar
• Patomchaiviwat V Paeratakul O Kulvanich P . Formation of inhalable rifampicin–poly (L-lactide) microparticles by supercritical anti-solvent process. AAPS PharmSciTech.9 (4), 1119–1129 (2008).
   PubMed Web of Science ®Google Scholar
• Prosapio V Reverchon E De Marco I . Formation of PVP/nimesulide microspheres by supercritical antisolvent coprecipitation. J. Supercrit. Fluids118, 19–26 (2016).
   Web of Science ®Google Scholar
• Moghaddam PH Ramezani V Esfandi E et al. Development of a nano-micro carrier system for sustained pulmonary delivery of clarithromycin. Powder Technol.239, 478–483 (2013).
   Web of Science ®Google Scholar
• Takami T Murakami Y . Development of PEG–PLA/PLGA microparticles for pulmonary drug delivery prepared by a novel emulsification technique assisted with amphiphilic block copolymers. Colloids and Surfaces B: Biointerfaces87 (2), 433–438 (2011).
   PubMed Web of Science ®Google Scholar
• Leung SSY Parumasivam T Gao FG et al. Production of inhalation phage powders using spray freeze drying and spray drying techniques for treatment of respiratory infections. Pharm. Res.33 (6), 1486–1496 (2016).
   PubMed Web of Science ®Google Scholar
• Kaialy W Martin GP Ticehurst MD et al. Characterisation and deposition studies of recrystallised lactose from binary mixtures of ethanol/butanol for improved drug delivery from dry powder inhalers. AAPS J.13 (1), 30–43 (2011).
   PubMed Web of Science ®Google Scholar
• Sou T Forbes RT Gray J et al. Designing a multi-component spray-dried formulation platform for pulmonary delivery of biopharmaceuticals: the use of polyol, disaccharide, polysaccharide and synthetic polymer to modify solid-state properties for glassy stabilisation. Powder Technol.287, 248–255 (2016).
   Web of Science ®Google Scholar
• Sarrate R Ticó JR Miñarro M et al. Modification of the morphology and particle size of pharmaceutical excipients by spray drying technique. Powder Technol.270 (Part A), 244–255 (2015).
   Google Scholar
• Mohajel N Najafabadi AR Azadmanesh K et al. Optimization of a spray drying process to prepare dry powder microparticles containing plasmid nanocomplex. Int. J. Pharm.423 (2), 577–585 (2012).
   PubMed Web of Science ®Google Scholar
• Zhang J Lv H Jiang K Gao Y . Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal. Int. J. Pharm.420 (1), 180–188 (2011).
   PubMed Web of Science ®Google Scholar
• Mohtar N Taylor KM Sheikh K Somavarapu S . Design and development of dry powder sulfobutylether-β-cyclodextrin complex for pulmonary delivery of fisetin. Eur. J. Pharm. Biopharm.113, 1–10 (2017).
   PubMed Web of Science ®Google Scholar
• Shoyele SA Sivadas N Cryan SA . The effects of excipients and particle engineering on the biophysical stability and aerosol performance of parathyroid hormone (1–34) prepared as a dry powder for inhalation. AAPS PharmSciTech.12 (1), 304–311 (2011).
   PubMed Web of Science ®Google Scholar
• Maltesen MJ Bjerregaard S Hovgaard L Havelund S Van De Weert M . Quality by design–spray drying of insulin intended for inhalation. Eur. J. Pharm. Biopharm.70 (3), 828–838 (2008).
   PubMed Web of Science ®Google Scholar
• Ung KT Rao N Weers JG Huang D Chan HK . Design of spray dried insulin microparticles to bypass deposition in the extrathoracic region and maximize total lung dose. Int. J. Pharm.511 (2), 1070–1079 (2016).
   PubMedGoogle Scholar
• Shen Z-G Chen W-H Jugade N et al. Fabrication of inhalable spore like pharmaceutical particles for deep lung deposition. Int. J. Pharm.430 (1), 98–103 (2012).
   PubMedGoogle Scholar
• Hu L Kong D Hu Q Gao N Pang S . Evaluation of high-performance curcumin nanocrystals for pulmonary drug delivery both in vitro and in vivo. Nanoscale Res. Lett.10 (1), 381 (2015).
   PubMedGoogle Scholar
• Kurniawansyah F Mammucari R Foster NR . Inhalable curcumin formulations by supercritical technology. Powder Technol.284, 289–298 (2015).
   Web of Science ®Google Scholar
• Kwok PCL Tunsirikongkon A Glover W Chan HK . Formation of protein nano-matrix particles with controlled surface architecture for respiratory drug delivery. Pharm. Res.28 (4), 788–796 (2011).
   PubMed Web of Science ®Google Scholar
• Ógáin ON Li J Tajber L Corrigan OI Healy AM . Particle engineering of materials for oral inhalation by dry powder inhalers. I–particles of sugar excipients (trehalose and raffinose) for protein delivery. Int. J. Pharm.405 (1), 23–35 (2011).
   PubMedGoogle Scholar
• Kang Y-Q Zhao C Chen A-Z et al. Study of lysozyme-loaded poly-L-lactide (PLLA) porous microparticles in a compressed CO2 antisolvent process. Materials6 (8), 3571–3583 (2013).
   PubMed Web of Science ®Google Scholar
• Abbas A Srour M Tang P Chiou H Chan HK Romagnoli JA . Sonocrystallisation of sodium chloride particles for inhalation. Chem. Eng. Sci.62 (9), 2445–2453 (2007).
   Web of Science ®Google Scholar
• Audouy SaL Van Der Schaaf G Hinrichs WLJ Frijlink HW Wilschut J Huckriede A . Development of a dried influenza whole inactivated virus vaccine for pulmonary immunization. Vaccine29 (26), 4345–4352 (2011).
   PubMed Web of Science ®Google Scholar
• Patil HP Murugappan S De Vries-Idema J et al. Comparison of adjuvants for a spray freeze-dried whole inactivated virus influenza vaccine for pulmonary administration. Eur. J. Pharm. Biopharm.93, 231–241 (2015).
   PubMed Web of Science ®Google Scholar
• Lakerveld R Kramer HJM Stankiewicz AI Grievink J . Application of generic principles of process intensification to solution crystallization enabled by a task-based design approach. Chemical Engineering and Processing: Process Intensification49 (9), 979–991 (2010).
   Web of Science ®Google Scholar
• Mullin JW . Crystallization. Butterworth-Heinemann, Oxford, UK (2001).
   Google Scholar
• Ragab D Rohani S Samaha MW El-Khawas FM El-Maradny HA . Crystallization of progesterone for pulmonary drug delivery. J. Pharm. Sci.99 (3), 1123–1137 (2010).
   PubMed Web of Science ®Google Scholar
• Sultana S Talegaonkar S Ali R Mittal G Ahmad FJ Bhatnagar A . Inhalation of alendronate nanoparticles as dry powder inhaler for the treatment of osteoporosis. J. Microencapsulation29 (5), 445–454 (2012).
   PubMed Web of Science ®Google Scholar
• Hu TT Zhao H Jiang LC Le Y Chen JF Yun J . Engineering pharmaceutical fine particles of budesonide for dry powder inhalation (DPI). Ind. Eng. Chem. Res.47 (23), 9623–9627 (2008).
   Web of Science ®Google Scholar
• Kaialy W Ticehurst MD Murphy J Nokhodchi A . Improved aerosolization performance of salbutamol sulfate formulated with lactose crystallized from binary mixtures of ethanol-acetone. J. Pharm. Sci.100 (7), 2665–2684 (2011).
   PubMed Web of Science ®Google Scholar
• Stoica C Verwer P Meekes H Van Hoof PJCM Kaspersen FM Vlieg E . Understanding the effect of a solvent on the crystal habit. Cryst. Growth Des.4 (4), 765–768 (2004).
   Web of Science ®Google Scholar
• Tam JM Mcconville JT Williams RO III Johnston KP . Amorphous cyclosporin nanodispersions for enhanced pulmonary deposition and dissolution. J. Pharm. Sci.97 (11), 4915–4933 (2008).
   PubMed Web of Science ®Google Scholar
• Pornputtapitak W El-Gendy N Berkland C . NanoCluster itraconazole formulations provide a potential engineered drug particle approach to generate effective dry powder aerosols. J. Aerosol Med. Pulmon. Drug Deliv.28 (5), 341–352 (2015).
   PubMed Web of Science ®Google Scholar
• Hu J Ng WK Dong Y Shen S Tan RBH . Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying. Int. J. Pharm.404 (1–2), 198–204 (2011).
   PubMed Web of Science ®Google Scholar
• Hu J Dong Y Pastorin G Ng WK Tan RBH . Spherical agglomerates of pure drug nanoparticles for improved pulmonary delivery in dry powder inhalers. J. Nanopart. Res.15 (4), 1560 (2013).
   Web of Science ®Google Scholar
• Lakerveld R Van Krochten JJH Kramer HJM . An air-lift crystallizer can suppress secondary nucleation at a higher supersaturation compared to a stirred crystallizer. Cryst. Growth Des.14 (7), 3264–3275 (2014).
   Web of Science ®Google Scholar
• Lakerveld R Verzijden NG Kramer H Jansens P Grievink J . Application of ultrasound for start-up of evaporative batch crystallization of ammonium sulfate in a 75-L crystallizer. AlChE J.57 (12), 3367–3377 (2011).
   Web of Science ®Google Scholar
• Ruecroft G Hipkiss D Ly T Maxted N Cains PW . Sonocrystallization: the use of ultrasound for improved industrial crystallization. Org. Process Res. Dev.9 (6), 923–932 (2005).
   Web of Science ®Google Scholar
• Gielen B Jordens J Thomassen LCJ Braeken L Van Gerven T . Agglomeration control during ultrasonic crystallization of an active pharmaceutical ingredient. Crystals7 (2), 40 (2017).
   Web of Science ®Google Scholar
• Wohlgemuth K Kordylla A Ruether F Schembecker G . Experimental study of the effect of bubbles on nucleation during batch cooling crystallization. Chem. Eng. Sci.64 (19), 4155–4163 (2009).
   Web of Science ®Google Scholar
• Vehring R Foss WR Lechuga-Ballesteros D . Particle formation in spray drying. J. Aerosol Sci.38 (7), 728–746 (2007).
   Web of Science ®Google Scholar
• Li HY Seville PC Williamson IJ Birchall JC . The use of amino acids to enhance the aerosolisation of spray-dried powders for pulmonary gene therapy. J. Gene Med.7 (3), 343–353 (2005).
   PubMed Web of Science ®Google Scholar
• Cuvelier B Eloy P Loira-Pastoriza C et al. Minimal amounts of dipalmitoylphosphatidylcholine improve aerosol performance of spray-dried temocillin powders for inhalation. Int. J. Pharm.495 (2), 981–990 (2015).
   PubMedGoogle Scholar
• Singh A Van Den Mooter G . Spray drying formulation of amorphous solid dispersions. Adv. Drug Deliv. Rev.100 (Suppl. C), 27–50 (2016).
   PubMedGoogle Scholar
• Gradon L Sosnowski TR . Formation of particles for dry powder inhalers. Adv. Powder Technol.25 (1), 43–55 (2014).
   Web of Science ®Google Scholar
• Newman SP Busse WW . Evolution of dry powder inhaler design, formulation, and performance. Resp. Med.96 (5), 293–304 (2002).
   PubMed Web of Science ®Google Scholar
• Bi R Shao W Wang Q Zhang N . Spray-freeze-dried dry powder inhalation of insulin-loaded liposomes for enhanced pulmonary delivery. J. Drug Targeting16 (9), 639–648 (2008).
   PubMed Web of Science ®Google Scholar
• D'addio SM Chan JGY Kwok PCL Prud'homme RK Chan HK . Constant size, variable density aerosol particles by ultrasonic spray freeze drying. Int. J. Pharm.427 (2), 185–191 (2012).
   PubMedGoogle Scholar
• D'addio SM Chan JGY Kwok PCL Benson BR Prud'homme RK Chan HK . Aerosol delivery of nanoparticles in uniform mannitol carriers formulated by ultrasonic spray freeze drying. Pharm. Res.30 (11), 2891–2901 (2013).
   PubMed Web of Science ®Google Scholar
• Niwa T Shimabara H Kondo M Danjo K . Design of porous microparticles with single-micron size by novel spray freeze-drying technique using four-fluid nozzle. Int. J. Pharm.382 (1–2), 88–97 (2009).
   PubMedGoogle Scholar
• Süverkrüp R Eggerstedt S Wanning S Kuschel M Sommerfeld M Lamprecht A . Collisions and coalescence in droplet streams for the production of freeze-dried powders. Colloids and Surfaces B: Biointerfaces141, 443–449 (2016).
   PubMed Web of Science ®Google Scholar
• Wanning S Süverkrüp R Lamprecht A . Jet-vortex spray freeze drying for the production of inhalable lyophilisate powders. Eur. J. Pharm. Sci.96, 1–7 (2017).
   PubMed Web of Science ®Google Scholar
• Wanning S Süverkrüp R Lamprecht A . Pharmaceutical spray freeze drying. Int. J. Pharm.488 (1–2), 136–153 (2015).
   PubMed Web of Science ®Google Scholar
• Wang ZL Finlay WH Peppler MS Sweeney LG . Powder formation by atmospheric spray-freeze-drying. Powder Technol.170 (1), 45–52 (2006).
   Web of Science ®Google Scholar
• Miyazaki Y Sugihara H Nishiura A Kadota K Tozuka Y Takeuchi H . Application of combinational supercritical CO2 techniques to the preparation of inhalable particles. J. Drug Deliv. Sci. Technol.36, 1–9 (2016).
   Web of Science ®Google Scholar
• Date AA Patravale VB . Current strategies for engineering drug nanoparticles. Curr. Opin. Coll. Interface Sci.9 (3–4), 222–235 (2004).
   Web of Science ®Google Scholar
• Thakur R Gupta RB . Rapid expansion of supercritical solution with solid cosolvent (RESS−SC) process: formation of griseofulvin nanoparticles. Ind. Eng. Chem. Res.44 (19), 7380–7387 (2005).
   Web of Science ®Google Scholar
• Foster NR Sih R . Development of a novel precipitation technique for the production of highly respirable powders: the atomized rapid injection for solvent extraction process. ACS Symp. Ser.1006, 309–347 (2009).
   Google Scholar
• Kurniawansyah F Duong HTT Luu TD et al. Inhalable curcumin formulations: micronization and bioassay. Chem. Eng. J.279, 799–808 (2015).
   Web of Science ®Google Scholar
• Pu Y Li Y Wang D Foster NR Wang JX Chen JF . A green route to beclomethasone dipropionate nanoparticles via solvent anti-solvent precipitation by using subcritical water as the solvent. Powder Technol.308, 200–205 (2017).
   Web of Science ®Google Scholar
• Reverchon E . Supercritical-assisted atomization to produce micro- and/or nanoparticles of controlled size and distribution. Ind. Eng. Chem. Res.41 (10), 2405–2411 (2002).
   Web of Science ®Google Scholar
• Cai MQ Guan YX Yao SJ Zhu ZQ . Supercritical fluid assisted atomization introduced by hydrodynamic cavitation mixer (SAA-HCM) for micronization of levofloxacin hydrochloride. J. Supercrit. Fluids43 (3), 524–534 (2008).
   Web of Science ®Google Scholar
• Shen YB Du Z Tang C Guan YX Yao SJ . Formulation of insulin-loaded N-trimethyl chitosan microparticles with improved efficacy for inhalation by supercritical fluid assisted atomization. Int. J. Pharm.505 (1–2), 223–233 (2016).
   PubMedGoogle Scholar
• Bałdyga J Czarnocki R Shekunov BY Smith KB . Particle formation in supercritical fluids-scale-up problem. Chem. Eng. Res. Des.88 (3), 331–341 (2010).
   Google Scholar
• Johnson KA . Preparation of peptide and protein powders for inhalation. Adv. Drug Deliv. Rev.26 (1), 3–15 (1997).
   PubMed Web of Science ®Google Scholar
• Djokić M Kachrimanis K Solomun L Djuriš J Vasiljević D Ibrić S . A study of jet-milling and spray-drying process for the physicochemical and aerodynamic dispersion properties of amiloride HCl. Powder Technol.262, 170–176 (2014).
   Web of Science ®Google Scholar
• Lee HJ Kang JH Lee HG et al. Preparation and physicochemical characterization of spray-dried and jet-milled microparticles containing bosentan hydrate for dry powder inhalation aerosols. Drug Des. Devel. Ther.10, 4017–4030 (2016).
   PubMed Web of Science ®Google Scholar
• Saleem IY Smyth HD . Micronization of a soft material: air-jet and micro-ball milling. AAPS PharmSciTech.11 (4), 1642–1649 (2010).
   PubMed Web of Science ®Google Scholar
• Moura C Neves F Costa E . Impact of jet-milling and wet-polishing size reduction technologies on inhalation API particle properties. Powder Technol.298, 90–98 (2016).
   Web of Science ®Google Scholar
• Kluge J Muhrer G Mazzotti M . High pressure homogenization of pharmaceutical solids. J. Supercrit. Fluids66, 380–388 (2012).
   Web of Science ®Google Scholar
• Malamatari M Somavarapu S Taylor KMG Buckton G . Solidification of nanosuspensions for the production of solid oral dosage forms and inhalable dry powders. Exp. Opin. Drug Deliv.13 (3), 435–450 (2016).
   PubMed Web of Science ®Google Scholar
• Afolabi A Akinlabi O Bilgili E . Impact of process parameters on the breakage kinetics of poorly water-soluble drugs during wet stirred media milling: a microhydrodynamic view. Eur. J. Pharm. Sci.51 (1), 75–86 (2014).
   PubMedGoogle Scholar
• Young PM Chan HK Chiou H Edge S Tee THS Traini D . The influence of mechanical processing of dry powder inhaler carriers on drug aerosolization performance. J. Pharm. Sci.96 (5), 1331–1341 (2007).
   PubMed Web of Science ®Google Scholar
• Chan JGY Duke CC Ong HX et al. A novel inhalable form of rifapentine. J. Pharm. Sci.103 (5), 1411–1421 (2014).
   PubMed Web of Science ®Google Scholar
• Shoyele SA Cawthorne S . Particle engineering techniques for inhaled biopharmaceuticals. Adv. Drug Deliv. Rev.58 (9–10), 1009–1029 (2006).
   PubMed Web of Science ®Google Scholar
• Heinemann L . The failure of exubera: are we beating a dead horse?J. Diabetes Sci. Technol. (Online)2 (3), 518–529 (2008).
   PubMedGoogle Scholar
• Kumar V Taylor MK Mehrotra A Stagner WC . Real-time particle size analysis using focused beam reflectance measurement as a process analytical technology tool for a continuous granulation-drying-milling process. AAPS PharmSciTech.14 (2), 523–530 (2013).
   PubMed Web of Science ®Google Scholar
• Agimelen OS Svoboda V Ahmed B et al. Monitoring crystal breakage in wet milling processes using inline imaging and chord length distribution measurements. arXiv preprint arXiv:1703.09186 (2017) ( Epub ahed of print).
   Google Scholar
• Liu LX Rashid A Marziano I White ET Howes T Litster JD . Flowability of binary mixtures of commercial and reprocessed ibuprofen through high shear wet milling (HSWM) with lactose. Adv. Powder Technol.23 (4), 454–458 (2012).
   Web of Science ®Google Scholar
• Sayyed Sallam A Nazzal S Alkhatib HS Darwazeh N . Quality by design: concept for product development of dry-powder inhalers. Pulmonary Drug Delivery: Advances and Challenges. NokhodchiAMartinGP ( Eds). Hoboken, NJ, USA, 321–338 (2015).
   Google Scholar
• Arora S Mahajan RR Kushwah V Baradia D Misra A Jain S . Development of voriconazole loaded large porous particles for inhalation delivery: effect of surface forces on aerosolisation performance, assessment of in vitro safety potential and uptake by macrophages. RSC Adv.5 (48), 38030–38043 (2015).
   Web of Science ®Google Scholar
• Ingvarsson PT Yang M Mulvad H Nielsen HM Rantanen J Foged C . Engineering of an inhalable dda/tdb liposomal adjuvant: a quality-by-design approach towards optimization of the spray drying process. Pharm. Res.30 (11), 2772–2784 (2013).
   PubMed Web of Science ®Google Scholar
• Karimi K Pallagi E Szabó-Révész P Csóka I Ambrus R . Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach. Drug Des. Devel. Ther.10, 3331 (2016).
   PubMed Web of Science ®Google Scholar
• Patil-Gadhe A Pokharkar V . Single step spray drying method to develop proliposomes for inhalation: a systematic study based on quality by design approach. Pulm. Pharmacol. Ther.27 (2), 197–207 (2014).
   PubMed Web of Science ®Google Scholar
• Mascia S Heider PL Zhang H et al. End-to-end continuous manufacturing of pharmaceuticals: integrated synthesis, purification, and final dosage formation. Angew. Chem. Int. Ed.52 (47), 12359–12363 (2013).
   PubMed Web of Science ®Google Scholar
• Lawton S Steele G Shering P Zhao L Laird I Ni XW . Continuous crystallization of pharmaceuticals using a continuous oscillatory baffled crystallizer. Org. Process Res. Dev.13 (6), 1357–1363 (2009).
   Web of Science ®Google Scholar
• Alvarez AJ Singh A Myerson AS . Crystallization of cyclosporine in a multistage continuous MSMPR crystallizer. Cryst. Growth Des.11 (10), 4392–4400 (2011).
   Web of Science ®Google Scholar
• Eder RJP Radl S Schmitt E et al. Continuously seeded, continuously operated tubular crystallizer for the production of active pharmaceutical ingredients. Cryst. Growth Des.10 (5), 2247–2257 (2010).
   Web of Science ®Google Scholar
• Eder RJP Schrank S Besenhard MO Roblegg E Gruber-Woelfler H Khinast JG . Continuous sonocrystallization of acetylsalicylic acid (ASA): control of crystal size. Cryst. Growth Des.12 (10), 4733–4738 (2012).
   Web of Science ®Google Scholar
• Hadiwinoto GD Kwok PCL Tong HHY Lakerveld R . Continuous crystallization of an active pharmaceutical ingredient for pulmonary drug delivery. Presented at : 20th International Symposium on Industrial Crystallization. Dublin, Ireland, 3–6 September 2017.
   Google Scholar